BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27014708)

  • 1. Pediatric Medullary Thyroid Carcinoma.
    Starenki D; Park JI
    J Pediatr Oncol; 2015; 3(2):29-37. PubMed ID: 27014708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medullary thyroid carcinoma in children.
    Viola D; Romei C; Elisei R
    Endocr Dev; 2014; 26():202-13. PubMed ID: 25231454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
    Frank-Raue K; Raue F
    Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer.
    Hedayati M; Zarif Yeganeh M; Sheikholeslami S; Afsari F
    Crit Rev Clin Lab Sci; 2016 Aug; 53(4):217-27. PubMed ID: 26678667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
    Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
    Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medullary Thyroid Cancer - Feature Review and Update on Systemic Treatment.
    Dabelić N; Jukić T; Fröbe A
    Acta Clin Croat; 2020 Jun; 59(Suppl 1):50-59. PubMed ID: 34219884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Management of Medullary Thyroid Carcinoma in Pediatric Age.
    Spinelli C; Strambi S; Rossi L; Elisei R; Massimino M
    Curr Pediatr Rev; 2016; 12(4):280-285. PubMed ID: 27834132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary thyroid carcinoma in children: current state of the art and future perspectives.
    Kiriakopoulos A; Dimopoulou A; Nastos C; Dimopoulou D; Dimopoulou K; Menenakos E; Zavras N
    J Pediatr Endocrinol Metab; 2022 Jan; 35(1):1-10. PubMed ID: 34592078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RET proto oncogene mutation detection and medullary thyroid carcinoma prevention.
    Yeganeh MZ; Sheikholeslami S; Hedayati M
    Asian Pac J Cancer Prev; 2015; 16(6):2107-17. PubMed ID: 25824727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of medullary thyroid carcinoma and MEN2 syndromes in childhood.
    Waguespack SG; Rich TA; Perrier ND; Jimenez C; Cote GJ
    Nat Rev Endocrinol; 2011 Aug; 7(10):596-607. PubMed ID: 21862994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
    Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of medullary thyroid carcinoma.
    Massoll N; Mazzaferri EL
    Clin Lab Med; 2004 Mar; 24(1):49-83. PubMed ID: 15157557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    J Endocr Soc; 2018 Aug; 2(8):933-943. PubMed ID: 30087948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of medullary thyroid cancer].
    Fujita T; Fujimori M
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1627-31. PubMed ID: 19838021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medullary thyroid carcinoma in children].
    Berdelou A; Hartl D; Al Ghuzlan A; Mirghani H; Chougnet C; Baudin E; Schlumberger M; Leboulleux S
    Bull Cancer; 2013; 100(7-8):780-8. PubMed ID: 23831771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation.
    González-Yebra B; Medrano ME; Mantilla A; Palma V; Colin C; Hernández DM; Tapia J; Dawson B; Salcedo M
    Endocr Pathol; 2003; 14(1):71-80. PubMed ID: 12746565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
    J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.